Patents
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
10/2001
10/11/2001DE10015866A1 Aryl- und Heteroarylsulfonate Aryl and Heteroarylsulfonate
10/11/2001CA2404545A1 Aryl and heteroaryl sulfonates
10/10/2001EP1142883A1 Novel heterocyclic compounds and drug compositions containing the same
10/10/2001EP1140875A1 Sulphonyloxazolamines as therapeutic active ingredients
10/10/2001EP1140874A1 Stereoselective synthesis of oxazoline derivative
10/10/2001EP1140809A1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
10/10/2001EP1140768A1 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
10/10/2001EP1140181A1 Combination therapy of radiation and a cox-2 inhibitor for the treatment of neoplasia
10/10/2001EP1140081A2 Improving mental performance by increasing brain insulin sensitivity
10/10/2001CN1316418A Benzene sulfonic derivative
10/10/2001CN1072655C New Heterocyclic aminomethyl compounds, process for preparing them and pharmaceutical composition containing their
10/09/2001US6300372 3-Cyano-3-(3,4-disubstituted) phenylcyclohexyl-1-carboxylates
10/09/2001US6300355 For therapy of cancer
10/09/2001US6300344 Heterocyclic compounds
10/09/2001CA2018960C Salicylaldehyde derivatives and salicylic acid derivatives and their sulfur analogs, their preparation and their use as herbicides and bioregulators
10/04/2001WO2001072723A1 Oxa(thia)zolidine derivative and anti-inflammatory drug
10/04/2001WO2001072302A1 Use of prostanoid ep4 receptor antagonists for the treatment of headache and assays for such antagonists
10/04/2001WO2001021577A3 Melanin concentrating hormone antagonist
10/04/2001US20010027194 Novel compounds useful as neuro-protective agents
10/04/2001EP1137839A2 Method for treating polyolefine- or polyester-based fibers to render them hydrophilic using heterocycles
10/04/2001EP0802909B1 Substituted oxazolidine calpain and/or cathepsin b inhibitors
10/03/2001CN1315831A Herbicidal phenoxypropionic acid N-alkyl-N-2-fluorophenyl amide compounds
10/03/2001CN1315320A Ether and amide compounds as medicide for treating glycuresis and preparing process thereof
10/03/2001CN1072222C Phenyloxazolidinones having C-C bond to 4-8 membered heterocyclic rings
10/03/2001CN1072221C 3-halo-3-heteroaryl carboxylic acid derivatives, method of preparing them and intermediates
10/02/2001US6297374 Nitroimino-nitromethylene—azole or-azine heterocyclic compounds, insecticidal compositions containing them, and insecticidal methods of using them
10/02/2001US6297267 Prostaglandin i2 agonist.
10/02/2001US6297260 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
10/02/2001US6297246 Benzoxazole derivatives; does not cause constipation as a side effect.
10/02/2001US6297242 Active against methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococci and penicillin- and cephalosporin-resistant streptococcus pneumoniae.
09/2001
09/27/2001WO2001070720A2 Carbocyclic side chain containing, n-substituted metalloprotease inhibitors
09/27/2001WO2001070682A2 Carbocyclic side chain containing metalloprotease inhibitors
09/27/2001WO2001032654A3 Novel heterocyclic compounds and their use as medicines
09/27/2001US20010024833 Reacting resin-bound 1,2-arylenediamine, 2-aminophenol, 2-aminothiophenol, or derivative with cyanogen bromide or aldehyde in the presence of oxidant
09/27/2001CA2404236A1 Carbocyclic side chain containing, n-substituted metalloprotease inhibitors
09/27/2001CA2403778A1 Carbocyclic side chain containing metalloprotease inhibitors
09/26/2001EP1135378A1 Benzamide derivatives and their use as apob-100 secretion inhibitors
09/26/2001EP1135377A1 Novel compounds
09/26/2001EP1135349A1 Process for preparing chiral compounds
09/26/2001EP0934252B1 Amide derivatives and their use as pesticides
09/26/2001CN1314899A Retinoid-associated receptor regulators
09/25/2001US6294580 For therapy and prophylaxis of type ii or non-insulin dependent diabetes mellitus, hyperglycaemia, dyslipidemia, type ii diabetes, type i diabetes, hypertriglyceridemia, syndrome x, insulin resistance, heart failure
09/25/2001US6294573 Reverse hydroxamate inhibitors of matrix metalloproteinases
09/25/2001US6294560 Synthesis of clasto-lactacystin β-lactone and analogs thereof
09/25/2001US6294185 Monomeric and polymeric cyclic amine and N-halamine compounds
09/25/2001US6294069 Method for preparing 2-aryl or 2-heterocyclyl chiral propionic acids and their esters
09/20/2001WO2001068619A1 5-amide substituted diarylamines as mex inhibitors
09/20/2001WO2001068591A1 Carboxylic acid derivatives as ip antagonists
09/20/2001WO2001068585A1 Novel amide compounds
09/20/2001US20010023259 Nutrients, drugs
09/20/2001CA2403017A1 5-amide substituted diarylamines as mex inhibitors
09/19/2001EP1134220A1 Benzoxazole derivatives and drugs containing the same as the active ingredient
09/19/2001EP1133493A1 Oxazolidinone antibacterial agents having a thiocarbonyl functionality
09/19/2001EP1133484A2 Heterocyclic derivatives and their use as integrin inhibitors
09/19/2001EP0923529B1 Substitute 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors
09/19/2001CN1313855A Inhibitors of alpha4Betal mediated cell adhesion alpha Beta
09/19/2001CN1071311C Process for manufacturing nitriles
09/18/2001US6291526 Treating a patient having parkinson's disease by administering 4-amino-3-(2-methylpropyl)butanoic acid.
09/18/2001US6291508 Potent ability to bind to retinoic acid receptors thus useful in treating psoriasis and rheumatoid arthritis.
09/18/2001US6291469 Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation
09/18/2001US6291432 (r)-n-(2-methylbenzyl)-3-((2s, 3s)-3-(n-(2-chromonecarbonyl)-l-asparaginyl)amino-2-hydroxy-4-phenylbutano yl)-5,5-dimethyl-1,3-thiazolidine-4-carboxamide can be given as a typical example of this compound.
09/18/2001US6291400 Herbicidal compounds
09/18/2001US6291183 A plurality of oligonucleotide linker molecules are attached on a planar solid support, photoremovable groups react with terminal ends of oligonucleotides, substrates exposed to light activate binding at selected areas; peptide synthesis
09/18/2001CA2039056C 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
09/13/2001WO2001066536A1 Process for the preparation of citalopram
09/13/2001WO2001066529A1 Nematicidal trifluorobutenes
09/13/2001WO2001012615A3 Fungicidal heteroaryl hepta-2,6-dienoic acid derivatives
09/13/2001US20010021782 Production of amide derivatives and intermediates therefor
09/13/2001US20010021775 Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor Xa
09/13/2001US20010021718 Antiscarring agent
09/13/2001CA2401861A1 Process for the preparation of citalopram
09/12/2001EP1132368A2 Process for the preparation of 2-fluoro-1,1-dichloro-acrylyl chloride
09/12/2001EP1131308A1 New piperazine and piperidine compounds
09/12/2001EP0888317B1 Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma
09/11/2001US6288239 5-trityloxymethyl-oxazolidinones and process for the preparation thereof
09/11/2001US6288238 Reaction of 3,4-cyclic boronic acid ester and 3,4-dihydroxy butyramide with alkali or alkaline earth metal hypohalite or hydroxide to produce 5-hydroxymethyl-2-oxazolidinone
09/11/2001US6288234 Fluorinated heterocyclic amido amine compounds as drugs
09/11/2001US6288096 Thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives
09/11/2001US6288090 Pharmaceutical composition
09/11/2001US6288086 N-hydroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
09/11/2001US6288055 Analgesic agents
09/07/2001WO2001064659A2 Indane derivatives and their use as cell adhesion inhibitors
09/07/2001WO2001064658A1 Preparation of mixtures of benzoxazolyl-stilbene compounds
09/07/2001WO2001019780A3 Novel derivatives of dicarboxylic acid having pharmaceutical properties
09/06/2001US20010020021 Metalloprotease inhibitor
09/05/2001EP1130017A2 Azole derivatives and their use as superoxide radical inhibitors
09/05/2001EP1130016A1 Thiocarbamic acid derivatives
09/05/2001CN1311772A New 3-aryl-2-hydoxy-propionic acid derivative I
09/04/2001US6284781 Anticancer agent
09/04/2001US6284767 Retroviral protease inhibiting compounds
09/04/2001US6284759 2-piperazinoalkylaminobenzo-azole derivatives: dopamine receptor subtype specific ligands
09/02/2001CA2299958A1 Preparation method for oxazoline compounds
08/2001
08/30/2001WO2001062721A1 Novel use of phenylheteroalkylamine derivatives
08/30/2001WO2001062708A1 Benzoic acid derivatives, process for producing the same and drugs containing the same as the active ingredient
08/30/2001WO2001062704A1 Novel use of phenylheteroalkylamine derivatives
08/30/2001US20010018525 Modulating blood glucose concentration
08/30/2001US20010018516 Crosslinking; coatings, inks, varnishes, surface treatment
08/30/2001DE10101305A1 Moisture-curable epoxy resin composition used as adhesive, sealant, capping agent, and coating composition, uses oxazolidine compound as latent curing agent
08/30/2001CA2397234A1 Novel use of phenylheteroalkylamine derivatives
08/30/2001CA2396960A1 Novel use of phenylheteroalkylamine derivatives